GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001138995
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 44 positions · Total reported value $5.23B · Top-10 concentration 62.0% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 69.6% · 13 new · 14 cut · 12 exited
Active Share (vs S&P 500): 87.0% · vs QQQ: 87.1% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +32.1% · vs SPY +17.3% · Prev Value $3.56B — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 44 equity positions with a combined reported value of $5.23B. The filing implies a focused portfolio: its ten largest positions account for 62.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.
The largest disclosed positions as of Q2 2026 were GPN ($646.27M), CVS ($499.13M), THC ($418.25M). By sector, the heaviest allocations are Health Care 28.5%, Consumer Discretionary 26.6%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+7.5pp), Industrials (+6.4pp) and away from Health Care (-2.5pp), Technology (-5.5pp).
Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 13 new positions, trimmed 14 and fully exited 12, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 55% of names.
The largest new positions opened in Q2 2026 were SPY ($194.16M), LLY ($69.29M), MKSI ($43.83M).
Of the 12 positions fully exited versus the prior quarter, the largest were QQQ ($189.43M), DXC ($111.82M), GTM ($95.11M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- QQQ INVESCO QQQ TR · prev qtr: $189.43M
- DXC DXC TECHNOLOGY CO · prev qtr: $111.82M
- GTM ZOOMINFO TECHNOLOGIES INC · prev qtr: $95.11M
- USFD US FOODS HLDG CORP · prev qtr: $35.41M
- Z ZILLOW GROUP INC CL C CAP STK · prev qtr: $32.68M
- LAD LITHIA MOTORS INC · prev qtr: $31.87M
- LION LIONSGATE STUDIOS CORP · prev qtr: $26.65M
- MYGN MYRIAD GENETICS INC · prev qtr: $24.35M
Insider Transactions (Form 4)
Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 44 US equity positions with a combined value of $5.23B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-73695 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 6 private funds, of which 6 hedge funds
Portfolio Structure
- 44 positions · $5.23B reported value (Q2 2026)
- Top 10 holdings = 62.0% of reported value
- Largest position: GPN (GLOBAL PMTS INC) at 12.4%
- Average position size: $118.86M
Sector Tilt
- Health Care 28.5%
- Consumer Discretionary 26.6%
- Industrials 14.0%
- (classified holdings cover 91% of value)
Quarterly Activity
- Q2 2026: 13 new, 14 added, 14 reduced, 12 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
8.91M | $646.27M | 12.36% | Add | |
| 2 |
|
4.82M | $499.13M | 9.54% | Reduce | |
| 3 |
|
2.24M | $418.25M | 8.00% | Add | |
| 4 |
|
627.24K | $314.47M | 6.01% | Add | |
| 5 |
|
1.27M | $303.09M | 5.79% | Add | |
| 6 |
|
918.20K | $275.87M | 5.28% | Add | |
| 7 |
|
1.15M | $218.29M | 4.17% | Add | |
| 8 |
|
356.84K | $201.00M | 3.84% | Add | |
| 9 |
|
260.00K | $194.16M | 3.71% | New | |
| 10 |
|
298.41K | $173.35M | 3.31% | Reduce | |
| 11 |
|
5.08M | $172.15M | 3.29% | Reduce | |
| 12 |
|
9.88M | $156.85M | 3.00% | Add | |
| 13 |
|
1.79M | $129.43M | 2.48% | Add | |
| 14 |
|
1.89M | $121.07M | 2.31% | Reduce | |
| 15 |
|
14.34M | $120.70M | 2.31% | Hold | |
| 16 |
|
412.22K | $113.64M | 2.17% | Reduce | |
| 17 |
|
254.22K | $100.98M | 1.93% | Reduce | |
| 18 |
|
1.20M | $90.98M | 1.74% | Reduce | |
| 19 |
|
401.07K | $90.97M | 1.74% | Add | |
| 20 |
|
13.50M | $81.78M | 1.56% | Add | |
| 21 |
|
205.79K | $77.88M | 1.49% | Reduce | |
| 22 |
|
57.77K | $69.29M | 1.32% | New | |
| 23 |
|
494.74K | $67.28M | 1.29% | Hold | |
| 24 |
|
3.10M | $58.95M | 1.13% | Add | |
| 25 |
|
413.33K | $48.55M | 0.93% | Add | |
| 26 |
|
994.58K | $47.49M | 0.91% | Reduce | |
| 27 |
|
65.20K | $47.14M | 0.90% | Reduce | |
| 28 |
|
98.53K | $43.83M | 0.84% | New | |
| 29 |
|
2.02M | $42.98M | 0.82% | Reduce | |
| 30 |
|
560.06K | $41.94M | 0.80% | New | |
| 31 |
|
148.91K | $37.47M | 0.72% | New | |
| 32 |
|
184.28K | $34.94M | 0.67% | New | |
| 33 |
|
1.92M | $31.76M | 0.61% | Hold | |
| 34 |
|
493.52K | $27.39M | 0.52% | Add | |
| 35 |
|
66.60K | $25.76M | 0.49% | New | |
| 36 |
|
265.58K | $24.22M | 0.46% | New | |
| 37 |
|
116.60K | $15.49M | 0.30% | New | |
| 38 |
|
252.17K | $15.18M | 0.29% | New | |
| 39 |
|
86.91K | $13.62M | 0.26% | New | |
| 40 |
|
84.81K | $13.32M | 0.26% | Reduce | |
| 41 |
|
404.97K | $9.90M | 0.19% | Reduce | |
| 42 |
|
113.10K | $4.83M | 0.09% | New | |
| 43 |
|
18.02K | $4.28M | 0.08% | New | |
| 44 |
|
58.32K | $4.12M | 0.08% | Reduce | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 50% R 50% F1 50% (modelled on 2026-Q1; 5/10 hit)
Historical Backtest (10 quarters)
Avg precision 73% · recall 73% · F1 73% · avg rank error 2.4 · Top-10 turnover 24%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 70% | 70% | 70% | THC · IWM · DXC · UHS · CTVA · GPN · CLVT · ALIT · MCK · UBER | THC · CI · CTVA · UHS · SPY · GPN · ALIT · DXC · IWM · ESI |
| 2024-Q2 | 90% | 90% | 90% | THC · CI · CTVA · UHS · GPN · SPY · ALIT · DXC · IWM · ESI | THC · CVS · CI · GPN · CTVA · IWM · ALIT · UHS · ESI · DXC |
| 2024-Q3 | 70% | 70% | 70% | CVS · THC · CI · GPN · CTVA · ALIT · IWM · UHS · ESI · TEVA | CVS · THC · GPN · CI · CTVA · IWM · DXC · CLVT · UHS · EXPE |
| 2024-Q4 | 70% | 70% | 70% | CVS · GPN · THC · CI · CTVA · IWM · DXC · CLVT · EXPE · TEVA | CVS · GPN · THC · ALIT · TEVA · DNB · CI · EXPE · UHS · DXC |
| 2025-Q1 | 80% | 80% | 80% | CVS · GPN · THC · ALIT · DNB · TEVA · EXPE · CI · DXC · UHS | CVS · THC · GPN · TEVA · ALIT · UHS · AMZN · GTM · CI · DXC |
| 2025-Q2 | 90% | 90% | 90% | CVS · THC · GPN · TEVA · ALIT · UHS · AMZN · GTM · USFD · DXC | CVS · THC · GPN · TEVA · GTM · ALIT · AMZN · CI · USFD · DXC |
| 2025-Q3 | 60% | 60% | 60% | CVS · THC · GPN · TEVA · GTM · AMZN · ALIT · CI · USFD · META | CVS · THC · GPN · SPY · TEVA · GTM · AMZN · TMO · DXC · UHS |
| 2025-Q4 | 80% | 80% | 80% | CVS · THC · GPN · SPY · TEVA · GTM · TMO · AMZN · DXC · UHS | CVS · TEVA · GPN · THC · AMZN · GTM · HYG · VTRS · TMO · DXC |
| 2026-Q1 | 70% | 70% | 70% | CVS · TEVA · GPN · THC · AMZN · GTM · TMO · VTRS · HYG · DXC | CVS · THC · AMZN · TEVA · QQQ · CI · AMD · TMO · VTRS · DXC |
| 2026-Q2 ★ | 50% | 50% | 50% | CVS · THC · AMZN · QQQ · TEVA · CI · AMD · VTRS · TMO · CNC | GPN · CVS · THC · TMO · AMZN · IWM · DHR · META · SPY · AMD |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 44 equity positions worth $5.23B in aggregate; its largest disclosed positions were GPN ($646.27M), CVS ($499.13M), THC ($418.25M).
How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?
GLENVIEW CAPITAL MANAGEMENT, LLC reported $5.23B of long equity holdings across 44 positions as of 2026-Q2. Top-10 holdings account for 62.0% of reported value.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.